Large Cap exit. 9.29.17
AGN Â invalidates Undervalued thesis, it faces many risks on recent Senate probes, FDA refusal letter for their Vraylar and Restasis patent. AGN -15% since pulished
AKBA our elite stock pick has hit 30% target. See our notes. 4.25.17
Elite small cap biotech pick hit target. Trim and trail. Blog article on 3/07/17Â http://www.precisiontrade365.com/new-small-cap-biotech-idea-3-7-17/ Â Chart on March 7, 2017 pick for elite membership. Â after chart as of April 4/25/17
New small cap biotech idea. (elite membership 12-months access only) 3.7.17
Long ago, Ben Graham taught me that price is what you pay, value is what you get. Whether we are talking about socks or stocks, I like buying quality merchandise when it is marked down. -Warren Buffett
TBRA has achieved profit goal, +700% since published on Aug, 1, 2016.
You need to divorce your mind from the crowd. The herd mentality causes all these IQ's to become paralyzed. I don't think investors are now acting more intelligently, despite the intelligence. Smart doesn't always equal rational. To be a successful investor you must divorce yourself from the fears and greed of the people around you, [...]